Faron Pharmaceuticals Oy (LON:FARN) Stock Crosses Above 50 Day Moving Average – Here’s What Happened

Faron Pharmaceuticals Oy (LON:FARN) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 176.23 ($2.28) and traded as high as GBX 220 ($2.85). Faron Pharmaceuticals Oy shares last traded at GBX 202.75 ($2.62), with a volume of 25,650 shares.

Faron Pharmaceuticals Oy Stock Performance

The company has a debt-to-equity ratio of 922.55, a quick ratio of 1.09 and a current ratio of 1.45. The firm has a 50 day moving average of GBX 176.23 and a two-hundred day moving average of GBX 185.01. The stock has a market cap of £272.20 million, a P/E ratio of -5.42 and a beta of 0.36.

About Faron Pharmaceuticals Oy

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.